Related Experiment Videos
[Manifestation of immunologic origin produced by toxic compounds]
1Institut national de la santé et de la recherche médicale U 28, hôpital Broussais, Paris.
La Revue Du Praticien
|October 1, 1991
Summary
Toxic agents can disrupt specific immune pathways, leading to autoimmune or hypersensitivity reactions. Understanding these mechanisms helps in developing predictive assays for drug-induced autoimmunity.
Area of Science:
- Immunology
- Toxicology
- Pharmacology
Context:
- Toxic agents can modulate both non-specific and specific immune responses.
- Drug-induced immune reactions can manifest as stimulatory (autoimmunity, hypersensitivity) or suppressive effects.
- Recent advancements have improved the understanding of mechanisms underlying hypersensitivity and autoimmunity.
Purpose:
- To elucidate the mechanisms by which toxic agents induce immunological manifestations.
- To differentiate between hypersensitivity and autoimmune reactions triggered by xenobiotics.
- To explore the role of drug metabolism and chemical structure in inducing autoimmune responses.
Summary:
- Toxic agents interfere with specific immune pathways, causing T-cell recognition of xenobiotics presented by MHC class II molecules (hypersensitivity).
- Drug metabolism can lead to reactive metabolites binding to enzymes, inducing autoimmune hepatitis.
- Thiol or metal-containing chemicals may cause autoimmunity by affecting T-B lymphocyte cooperation.
Impact:
- Enhanced understanding of drug-induced autoimmunity and hypersensitivity.
- Potential for developing predictive assays to identify immunotoxic drugs.
- Improved strategies for managing or preventing adverse immune reactions to xenobiotics.